Literature DB >> 9737715

Altered regulation of L-type channels by protein kinase C and protein tyrosine kinases as a pathophysiologic effect in retinal degeneration.

S Mergler1, K Steinhausen, M Wiederholt, O Strauss.   

Abstract

The effect of protein tyrosine kinases (PTK) on L-type calcium channels in cultured retinal pigmented epithelium (RPE) from rats with retinal dystrophy was investigated. Barium currents through Bay K 8644 (10(-6) M) sensitive L-type channels were measured using the patch-clamp technique. The current density of L-type currents is twice as high and the inactivation time constants are much slower than in cells from nondystrophic control rats. Application of the PTK blockers genistein, lavendustin A, and herbimycin A (all 5 x 10(-6) M) led to an increase of L-type currents. Intracellular application of pp60c-src (30 U/ml) via the patch pipette led to a transient decrease of L-type currents. The protein kinase A (PKA) and PKG blocker H9 (10(-6) M) showed no effect on L-type currents. However, the protein kinase C blocker chelerythrine (10(-5) M) reduced these currents. Up-regulation of PKC by 10(-6) M 4beta-phorbol-12 myristate-13 acetate (PMA) led to a decrease of L-type currents. Additional application of genistein led to a further decrease of these currents. However, intracellular application of pp60(c-src) in PMA-treated cells led to a transient increase of L-type currents. Investigating the calcium response to bFGF application showed that RPE cells from RCS rats used different pathways than control RPE cells to increase cytosolic free calcium. This different pathway does not involve the activation of L-type channels. The present study with RPE cells from rats with retinal dystrophy shows a changed integration of PTK and PKC in channel regulation. Considering the altered response to bFGF in RCS-RPE cells, this disturbed regulation of L-type channels by tyrosine kinases is involved in the etiology of retinal degeneration in RCS rats.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9737715     DOI: 10.1096/fasebj.12.12.1125

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  7 in total

1.  Expression of Orai genes and I(CRAC) activation in the human retinal pigment epithelium.

Authors:  Sönke Cordeiro; Olaf Strauss
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-07-06       Impact factor: 3.117

2.  Alterations of sodium and potassium channels of RGCs in RCS rat with the development of retinal degeneration.

Authors:  Zhongshan Chen; Yanping Song; Junping Yao; Chuanhuang Weng; Zheng Qin Yin
Journal:  J Mol Neurosci       Date:  2013-08-10       Impact factor: 3.444

3.  Nifedipine alters the light-rise of the electro-oculogram in man.

Authors:  Paul A Constable
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-01-08       Impact factor: 3.117

4.  Protein and gene expression of Ca2+ channel isoforms in murine colon: effect of inflammation.

Authors:  Minho Kang; Nemat Morsy; Xiaochun Jin; Florea Lupu; Hamid I Akbarali
Journal:  Pflugers Arch       Date:  2004-12       Impact factor: 3.657

5.  Functional Voltage-Gated Calcium Channels Are Present in Human Embryonic Stem Cell-Derived Retinal Pigment Epithelium.

Authors:  Iina Korkka; Taina Viheriälä; Kati Juuti-Uusitalo; Hannele Uusitalo-Järvinen; Heli Skottman; Jari Hyttinen; Soile Nymark
Journal:  Stem Cells Transl Med       Date:  2018-11-04       Impact factor: 6.940

6.  Inhibitory Effects of Genistein on Vascular Smooth Muscle Cell Proliferation Induced by Ox-LDL: Role of BKCa Channels.

Authors:  Bing Bai; Nanjuan Lu; Wei Zhang; Jinghan Lin; Tingting Zhao; Shanshan Zhou; Elona Khasanova; Liming Zhang
Journal:  Anal Cell Pathol (Amst)       Date:  2020-12-13       Impact factor: 2.916

7.  Voltage-dependent Ca2+ channels, not ryanodine receptors, activate Ca2+-dependent BK potassium channels in human retinal pigment epithelial cells.

Authors:  Sönke Wimmers; Claire Halsband; Sebastian Seyler; Vladimir Milenkovic; Olaf Strauss
Journal:  Mol Vis       Date:  2008-12-15       Impact factor: 2.367

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.